On October 2, WUXI XDC fell 3.66% in regular trading, trading at 78.1 HKD/share, with turnover of approximately 28.73 million HKD.

On the news front, the lingering impact of a major shareholder disposal continues to weigh on sentiment. WuXi AppTec offloaded 53.524 million shares of WUXI XDC via block trade at the end of August at an average price of 73.23 HKD per share, reducing its stake from 18.36% to 14.14% and involving approximately 3.92 billion HKD in proceeds. The concentrated sell-down has continued to suppress market confidence in the stock over subsequent weeks.

Sector-wide, Life Sciences Tools and Services stocks extended their decline broadly. Among peers, INSILICO fell 6.91%, XTALPI fell 5.38%, GENSCRIPT BIO fell 4.15%, WUXI BIO fell 3.21%, and WUXI APPTEC fell 3.16%, with systematic sector weakness amplifying downward pressure on individual names.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)